Tempest Therapeutics, Inc. 8-K

What Happened

• Tempest Therapeutics, Inc. (TPST) filed a Form 8-K on February 11, 2026 (Item 7.01, Regulation FD Disclosure) stating it intends to post an updated corporate presentation dated February 2026 to the "News, Events & Presentations" subsection of the Investors tab on its website (www.tempesttx.com).
• A copy of the presentation is attached to the filing as Exhibit 99.1 and is incorporated by reference.

Key Details

• Filing date: February 11, 2026 (Form 8-K, Item 7.01).
• Presentation dated: February 2026; will be posted to the Investors > News, Events & Presentations section at www.tempesttx.com.
• Exhibit included: Exhibit 99.1 — Investor Presentation (and Inline XBRL cover page file, Exhibit 104, is included with the filing).

Why It Matters

• The company is using a Regulation FD disclosure to make updated corporate and investor materials broadly available; investors should review the February 2026 presentation on Tempest’s website for the company’s latest overview, strategic messaging, pipeline summaries and investor-facing information.
• This is a non-financial disclosure (presentation update) rather than an earnings, executive change, or transaction filing; it signals refreshed investor communications but does not itself report quarterly results or material transactions.